Commentary

Commentary

America Shouldn’t Buy Into Single-Payer Mirage

Will the seventh time be the charm? Sen. Bernie Sanders sure hopes so. Vermont’s senior senator just introduced his latest bid to install Medicare for All in the United States. In seven of the last eight Congresses, dating back to 2011, he’s offered legislation to launch a government takeover of ...
California

Newsom’s ed budget: high spending, low results

Despite a $12 billion budget deficit, Governor Gavin Newsom still proposes to spend more on the state’s public schools, despite findings of a Georgetown University study showing that California is not getting education bang for its taxpayer buck. Newsom’s updated budget includes $137.8 billion in total education funding, which consists ...
California

Can California afford costly climate change programs in a grim budget year?

It was not supposed to be this way. In the throes of last year’s budget turmoil, California’s spending plan at that time was supposed to bring stability. Yet here we are. Another May Revision, another budget deficit — this time for $12 billion. While Gov. Gavin Newsom is right — ...
Commentary

Potential Tariffs Will Harm Patients In The Name Of Protecting Them

Two months ago, the Commerce Department launched an investigation into whether pharmaceutical imports pose a threat to national security (i.e., a Section 232 investigation). Not only are the investigation’s accusations groundless, implementing the proposed remedy – more tariffs – will create the very problems that the investigation hopes to avoid. ...
Commentary

Away With Provider Taxes

The Centers for Medicare & Medicaid Services recently published a rule targeting “provider taxes,” a financing gimmick states use to harvest extra Medicaid dollars from the federal government. Good on the Trump administration. Over the last decade and a half, states have exploited provider taxes and other financing loopholes to ...
Commentary

Tying U.S. Drug Prices To Foreign Markets Risks Innovation And Lives

Earlier this month, President Donald Trump signed what he called “one of the most consequential Executive Orders in our Country’s history.” The order is essentially an updated version of his administration’s 2020 “Most Favored Nation” policy. It directs pharmaceutical companies to tie the U.S. prices of their drugs to the ...
Commentary

Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans

Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term. Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.” The idea is to bring other developed countries’ lower drug prices to the United ...
Commentary

Colorado Gov. Polis’ new ‘study’ is a waste of time

The drive for single-payer health care won’t die. Gov. Jared Polis just signed legislation to spend $400,000 on a new “study” of how to bring government-run health care to the state. It’s a colossal waste of time and money. Decades of evidence from Canada and the United Kingdom show that ...
Commentary

Threatened With Legal Action, State Makes U-Turn on Electric Truck Mandates

Pressured by legal action from seventeen states that would have been impacted, California has agreed to not just drop enforcement of its electric truck mandate, but to repeal it entirely. Following the governor’s 2020 executive order that banned the sales of new internal-combustion engine cars in 2035, the state Air ...
Commentary

Trump Should Support Effective Drug Policy Reforms Not The MFN Gimmick

The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted drugs at the lowest price in other industrialized countries. The president’s justification for the MFN is simple: Americans are ...
Commentary

America Shouldn’t Buy Into Single-Payer Mirage

Will the seventh time be the charm? Sen. Bernie Sanders sure hopes so. Vermont’s senior senator just introduced his latest bid to install Medicare for All in the United States. In seven of the last eight Congresses, dating back to 2011, he’s offered legislation to launch a government takeover of ...
California

Newsom’s ed budget: high spending, low results

Despite a $12 billion budget deficit, Governor Gavin Newsom still proposes to spend more on the state’s public schools, despite findings of a Georgetown University study showing that California is not getting education bang for its taxpayer buck. Newsom’s updated budget includes $137.8 billion in total education funding, which consists ...
California

Can California afford costly climate change programs in a grim budget year?

It was not supposed to be this way. In the throes of last year’s budget turmoil, California’s spending plan at that time was supposed to bring stability. Yet here we are. Another May Revision, another budget deficit — this time for $12 billion. While Gov. Gavin Newsom is right — ...
Commentary

Potential Tariffs Will Harm Patients In The Name Of Protecting Them

Two months ago, the Commerce Department launched an investigation into whether pharmaceutical imports pose a threat to national security (i.e., a Section 232 investigation). Not only are the investigation’s accusations groundless, implementing the proposed remedy – more tariffs – will create the very problems that the investigation hopes to avoid. ...
Commentary

Away With Provider Taxes

The Centers for Medicare & Medicaid Services recently published a rule targeting “provider taxes,” a financing gimmick states use to harvest extra Medicaid dollars from the federal government. Good on the Trump administration. Over the last decade and a half, states have exploited provider taxes and other financing loopholes to ...
Commentary

Tying U.S. Drug Prices To Foreign Markets Risks Innovation And Lives

Earlier this month, President Donald Trump signed what he called “one of the most consequential Executive Orders in our Country’s history.” The order is essentially an updated version of his administration’s 2020 “Most Favored Nation” policy. It directs pharmaceutical companies to tie the U.S. prices of their drugs to the ...
Commentary

Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans

Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term. Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.” The idea is to bring other developed countries’ lower drug prices to the United ...
Commentary

Colorado Gov. Polis’ new ‘study’ is a waste of time

The drive for single-payer health care won’t die. Gov. Jared Polis just signed legislation to spend $400,000 on a new “study” of how to bring government-run health care to the state. It’s a colossal waste of time and money. Decades of evidence from Canada and the United Kingdom show that ...
Commentary

Threatened With Legal Action, State Makes U-Turn on Electric Truck Mandates

Pressured by legal action from seventeen states that would have been impacted, California has agreed to not just drop enforcement of its electric truck mandate, but to repeal it entirely. Following the governor’s 2020 executive order that banned the sales of new internal-combustion engine cars in 2035, the state Air ...
Commentary

Trump Should Support Effective Drug Policy Reforms Not The MFN Gimmick

The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted drugs at the lowest price in other industrialized countries. The president’s justification for the MFN is simple: Americans are ...